Connect to share and comment

Italy approves law on controversial stem cell therapy

Italian lawmakers on Wednesday gave their final approval to a law that allows limited use of a controversial type of stem cell therapy which has been condemned by many scientists but has given hope to families of terminally-ill children. The law gives the go-ahead for therapy being carried out by the Stamina Foundation on dozens of patients to continue, and allows for an 18-month period of clinical trials for the procedure, which had previously been blocked by Italian authorities.

Researchers make embryonic stem cells from skin

US researchers reported a breakthrough in stem cell research on Wednesday, describing how they have turned human skin cells into embyronic stem cells for the first time. The method described by Oregon State University scientists in the journal Cell, would not likely be able to create human clones, said Shoukhrat Mitalipov, senior scientist at the Oregon National Primate Research Center.

CORRECTED: Researchers make embryonic stem cells from skin

US researchers have reported a breakthrough in stem cell research, describing how they have turned human skin cells into embyronic stem cells for the first time. The method described Wednesday by Oregon Health and Science University scientists in the journal Cell, would not likely be able to create human clones, said Shoukhrat Mitalipov, senior scientist at the Oregon National Primate Research Center.

Researchers make embryonic stem cells from skin

US researchers have reported a breakthrough in stem cell research, describing how they have turned human skin cells into embyronic stem cells for the first time. The method described Wednesday by Oregon State University scientists in the journal Cell, would not likely be able to create human clones, said Shoukhrat Mitalipov, senior scientist at the Oregon National Primate Research Center. But it is an important step in research because it does not require the use of embryos in creating the type of stem cell capable of transforming into any other type of cell in the body.

Study shows that adventure shapes the individual

The act of exploring helps shape the brain and adventuring is what makes each individual different, according to a study out Thursday by researchers in Germany. The findings published in the US journal Science may offer new paths to treating psychiatric diseases, scientists said. Researchers sought to pin down why identical twins are not perfect replicas of each other, even when they have been raised in the same environment, and studied the matter using 40 genetically identical mice.

Study shows that adventure shapes the individual

The act of exploring helps shape the brain and adventuring is what makes each individual different, according to a study out Thursday by researchers in Germany. The findings published in the US journal Science may offer new paths to treating psychiatric diseases, scientists said. Researchers sought to pin down why identical twins are not perfect replicas of each other, even when they have been raised in the same environment, and studied the matter using 40 genetically identical mice.

Government moving to regulate stem cell therapy in the Bahamas

The Bahamas government says it is moving to regulate stem research in the country indicating that it is fully aware of the concerns raised in the public domain.Prime Minister Perry Christie, who piloted legislation on the issue as well as proposed regulations to implement the Act, told legislators that the authorities had commissioned a task force to study the matter.“The task force issued a thorough and thoughtful report summarising the current state of stem cell science and of ethical debate regarding related controversial issues,” he said, adding that his administration ha

Japan researchers close in on stem cell trial

Researchers in Japan have moved one step closer to clinical trials using adult stem cells in a therapy they hope will prove a cure for common sight problems, an official said Thursday. The ethics committee at the Institute for Biomedical Research and Innovation in Kobe, west Japan, on Wednesday approved a trial treatment for age-related macular degeneration (AMD) using induced Pluripotent Stem (iPS) cells.

UPDATE 1-US high court won't review federal embryonic stem cell funds

By Terry Baynes Jan 7 (Reuters) - The U.S. Supreme Court on Monday refused to review a challenge to federal funding of human embryonic stem cell research brought by two researchers who said the U.S. National Institutes of Health rules on such studies violate federal law.
Syndicate content